DELMONTE, ANNAMARIA
 Distribuzione geografica
Continente #
AS - Asia 199
NA - Nord America 104
EU - Europa 71
SA - Sud America 14
AF - Africa 6
Totale 394
Nazione #
US - Stati Uniti d'America 101
SG - Singapore 69
CN - Cina 66
VN - Vietnam 28
HK - Hong Kong 17
IT - Italia 16
GB - Regno Unito 14
DE - Germania 12
BR - Brasile 11
KR - Corea 10
IN - India 6
SE - Svezia 6
FR - Francia 5
IE - Irlanda 4
ZA - Sudafrica 4
BG - Bulgaria 3
FI - Finlandia 3
AR - Argentina 2
CA - Canada 2
NL - Olanda 2
RU - Federazione Russa 2
BD - Bangladesh 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
IQ - Iraq 1
JP - Giappone 1
LT - Lituania 1
MX - Messico 1
SC - Seychelles 1
TG - Togo 1
UA - Ucraina 1
Totale 394
Città #
Singapore 50
Hefei 21
Ashburn 17
Hong Kong 17
Santa Clara 14
Beijing 11
Southend 11
Seoul 10
Bologna 8
Fairfield 7
Hanoi 6
Chandler 5
Boardman 4
Dallas 4
Dublin 4
Houston 4
Princeton 4
Redondo Beach 4
Helsinki 3
Jinan 3
Johannesburg 3
New York 3
Shanghai 3
Sofia 3
Atlanta 2
Bengaluru 2
Changsha 2
Fuzhou 2
Ho Chi Minh City 2
Los Angeles 2
Rome 2
The Dalles 2
Westminster 2
Woodbridge 2
Alta Floresta d'Oeste 1
Barueri 1
Berlin 1
Bexley 1
Bragado 1
Buffalo 1
Bühl 1
Cambridge 1
Canoas 1
Changping 1
Chicago 1
Costa Mesa 1
Curitiba 1
Da Nang 1
Des Moines 1
Dhaka 1
Düsseldorf 1
Embu das Artes 1
Erbil 1
Falkenstein 1
Florence 1
Frankfurt am Main 1
Hacienda El Triunfo 1
Hebei 1
Kato Synoikia Trikalon 1
Lauterbourg 1
Lomé 1
Maceió 1
Marituba 1
Mexico City 1
Milan 1
Montreal 1
Muriaé 1
Nam Định 1
Nanjing 1
Nanyang 1
Orem 1
Pico Truncado 1
Portsmouth 1
Raleigh 1
Redwood City 1
Ribeirão Preto 1
Salt Lake City 1
Shanwei 1
Shijiazhuang 1
Sorocaba 1
São Paulo 1
Taiyuan 1
Taizhou 1
Tiền Giang 1
Tokyo 1
Tongling 1
Vancouver 1
Visakhapatnam 1
Wilmington 1
Zhuhai 1
Totale 295
Nome #
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience 124
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO) 119
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population 74
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (British Journal of Cancer, (2020), 123, 1, (26-32), 10.1038/s41416-020-0845-3) 46
ROS1-rearranged Non–small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS) 43
Totale 406
Categoria #
all - tutte 1.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.305


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 1 0 0 18
2021/202227 1 0 2 4 3 1 1 2 1 3 5 4
2022/202332 2 3 1 8 0 2 1 0 6 1 5 3
2023/202415 0 2 1 0 1 5 0 1 2 1 1 1
2024/2025116 3 12 7 6 21 7 4 3 0 15 9 29
2025/2026154 33 33 29 18 25 16 0 0 0 0 0 0
Totale 406